Biogen Inc. opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Biogen Inc.

Patent Number:
Title:
Liquid Pharmaceutical Composition
Opposition Date:
Oct 5, 2022
Patent Number:
Title:
Liquid Pharmaceutical Composition
Opposition Date:
Jul 22, 2020
Patent Number:
Title:
Pharmaceutical Anti-Tnf-Alpha Antibody Formulation
Opposition Date:
Jun 19, 2019
Patent Number:
Title:
Liquid Pharmaceutical Composition
Applicant:
Opposition Date:
Mar 26, 2019

Want to track Biogen Inc.?

Feel free to send us a message here and we will get back to you